Target
Somatostatin receptor type 2
Ligand
BDBM50075279
Substrate
n/a
Meas. Tech.
ChEBML_200682
Ki
7.3±n/a nM
Citation
 Pasternak, APan, YMarino, DSanderson, PEMosley, RRohrer, SPBirzin, ETHuskey, SEJacks, TSchleim, KDCheng, KSchaeffer, JMPatchett, AAYang, L Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclization. Bioorg Med Chem Lett 9:491-6 (1999) [PubMed]  Article 
Target
Name:
Somatostatin receptor type 2
Synonyms:
SOMATOSTATIN SST2 | SRIF-1 | SS-2-R | SS2-R | SS2R | SSR2_HUMAN | SSTR2 | Somatostatin receptor type 2 (SSTR2)
Type:
Enzyme
Mol. Mass.:
41344.94
Organism:
Homo sapiens (Human)
Description:
P30874
Residue:
369
Sequence:
MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
  
Inhibitor
Name:
BDBM50075279
Synonyms:
(2R,3S)-N-(5-Amino-[1,3]dioxan-2-ylmethyl)-2-[3-(3,4-dichloro-benzyl)-2-oxo-imidazolidin-1-yl]-3-(1H-indol-3-yl)-butyramide | CHEMBL147092
Type:
Small organic molecule
Emp. Form.:
C27H31Cl2N5O4
Mol. Mass.:
560.472
SMILES:
C[C@H]([C@@H](N1CCN(Cc2ccc(Cl)c(Cl)c2)C1=O)C(=O)NC[C@H]1OC[C@H](N)CO1)c1c[nH]c2ccccc12 |wU:2.2,22.23,wD:25.27,1.0,(-.86,3.13,;-.83,1.59,;.5,.83,;1.83,1.6,;1.82,3.14,;4.49,3.17,;4.49,1.63,;5.84,.86,;7.16,1.65,;8.5,.88,;9.83,1.66,;9.81,3.2,;11.14,3.98,;8.47,3.96,;8.45,5.5,;7.15,3.17,;3.16,.84,;3.18,-.7,;.5,-.71,;2.05,-.71,;-.27,-2.04,;.47,-3.37,;-.3,-4.7,;.47,-6.04,;-.32,-7.37,;-1.86,-7.36,;-2.65,-8.68,;-2.61,-6,;-1.84,-4.69,;-2.16,.81,;-2.16,-.72,;-3.49,-1.5,;-4.82,-.73,;-6.15,-1.5,;-7.48,-.73,;-7.48,.81,;-6.15,1.58,;-4.82,.81,)|
Structure:
Search PDB for entries with ligand similarity: